FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 28 strategically located sites across 7 European countries, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments.
Ameli-Biogroup Ltd is a physician-led clinical research site partnered with leading pharmaceutical companies to execute rare-disease and specialty trials. Founded on a philosophy…
OrciTrials provides specialised clinical research services for the bio-tech and pharmaceutical industries, covering all therapeutic areas and facets of clinical development. With…
A UK Primary Care Research Site Network. Over 6.5Million patients in our network, with specialist sites for various niche therapeutic area.